Semaglutide (Ozempic)

---

Membership price= $62.50 weekly

Semaglutide (Ozempic) is a once-weekly injectable medication prescribed to help manage weight in adults with a BMI >30 or a BMI>27 with comorbidities (high blood pressure, diabetes, high cholesterol). It is  administered subcutaneously in the abdomen, thigh, or upper arm,  It mimics the effects of glucagon-like peptide-1 (GLP-1), which increases insulin production, impacts blood sugar, and supports healthy metabolism. 

Semaglutide has been approved by the FDA under various brand names for the treatment of chronic weight management and obesity.

-Reduces lipid accumulation in the liver

-Stimulates insulin secretion 

-Delays stomach emptying 

-Slows intestinal motility 

-Significant appetite reduction 

-Reduces cravings for sweets and fatty foods

-Reduces the risk of future cardiovascular events

* titration schedule and final dosage may vary by patient's tolerance of medication

Membership includes office administration weekly or a monthly box delivered to clinic or your home and will include the following:

Month supply vial(s) of Semaglutide

Needle syringes

Alcohol wipes

Sharps container

This medication is injected under the skin. You will be taught how to prepare and give it to yourself. Take it as directed on the prescription label. It is given once every week (every 7 days). It is important that you put your used needles syringe in a special sharps container. Do not put them in a trash can.  Over dosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.

Contraindications and side effects:

Semaglutide has a boxed warning (the strictest warning) from the FDA about a risk of thyroid C-cell tumors. This is because animal studies found that rodents developed thyroid tumors when exposed to GLP-1 agonists. However human studies have yet to confirm this risk.

You shouldn’t take Semaglutide if you or your family have a history of medullary thyroid cancer or multiple endocrine neoplasia (MEN) type 2. Contact your healthcare provider immediately if you notice signs or symptoms of thyroid cancer. These include a lump in your neck or jaw pain. 

• You may not take SEMAGLUTIDE if you are pregnant, have a personal history of pancreatitis, or a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia 2A or 2B.
• If you take Semaglutide with insulin or an insulin secretagogue (eg, a sulfonylurea), blood glucose should be monitored, and a dose reduction in the insulin or the sulfonylurea may be necessary to avoid hypoglycemia.
• Rare cases of angioedema and anaphylaxis have been reported with Semaglutide.
• Patients with diabetic retinopathy should be monitored for complications
• It’s common to experience nausea, vomiting, or diarrhea. These are generally mild to moderate and improve over time.
• Gastrointestinal symptoms could occur upon starting the medication and when increasing the dose each month.
• If you experience nausea upon starting the medication, contact us if you don’t feel better after a few days and we can prescribe a temporary medication for nausea (ondansetron/Zofran).
• Please read the “Up to Date” patient education handout for a complete list of possible side effects. (We will give to you at your visit)